"L’Institut du Cerveau est un centre de recherche de dimension internationale, sans équivalent dans le monde, innovant dans sa conception comme dans son organisation. En réunissant en un même lieu malades, médecins et chercheurs, l’objectif est de permettre la mise au point rapide de traitements pour les lésions du système nerveux afin de les appliquer aux patients dans les meilleurs délais. Venus de tous les horizons et de tous les pays, les meilleurs scientifiques y développent les recherches les plus à la pointe dans ce domaine."

During the past decade, Institut Du Cerveau Et de La Moelle Epiniere conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 4 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 4 clinical trials were completed. i.e. 44.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institut Du Cerveau Et de La Moelle Epiniere" #1 sponsor was "Institut National de la Santé Et de la Recherche Médicale, France" with 10 trials, followed by "Wave Life Sciences Ltd." with 5 trials sponsored, "BioSerenity" with 3 trials sponsored, "PTC Therapeutics" with 2 trials sponsored and "CHDI Foundation, Inc." with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Du Cerveau Et de La Moelle Epiniere" #1 collaborator was "APHP" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator and "Fondation ARSEP" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Institut Du Cerveau Et de La Moelle Epiniere" are "Healthy" (4 trials), "Essential Tremor" (3 trials), "Huntington Disease" (3 trials), "Huntington's Disease" (3 trials) and "Friedreich Ataxia" (2 trials). Many other conditions were trialed in "Institut Du Cerveau Et de La Moelle Epiniere" in a lesser frequency.

Most popular intervention types in "Institut Du Cerveau Et de La Moelle Epiniere" are "Device" (11 trials), "Drug" (7 trials), "Behavioral" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Vatiquinone" (2 trials), "WVE-120101" (2 trials), "WVE-120102" (2 trials) and "tDCS" (2 trials). Other intervention names were less common.

The vast majority of trials in "Institut Du Cerveau Et de La Moelle Epiniere" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Institut Du Cerveau Et de La Moelle Epiniere". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 6 completed trials in Institut Du Cerveau Et de La Moelle Epiniere, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Institut Du Cerveau Et de La Moelle Epiniere, 5 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 13 trials that are defined as “Not Applicable".

Institut Du Cerveau Et de La Moelle Epiniere has several departments that took part in Clinical trials: "ICM, CIC Neurosciences" - 2 trials